EXTRACTION, EVALUATION, MANUFACTURING, FORMULATION, ANALYSIS, CLINICAL FOR THE DELIVERY OF METABOLIC ENERGY BY LIPOSOMAL TECHNOLOGY USING MEDIUM-CHAIN TRIGLYCERIDE IN THE FORM OF ORAL ENERGY OF SHOTS
Main Article Content
Keywords
Medium-chain triglycerides, MCT oil, C8, C10, β-oxidation, Ketogenesis, Energy delivery, Oral energy shot, Stability, Preclinical safety, clinical, liposomal
Abstract
Medium-chain triglycerides (MCTs) are rapidly metabolized dietary lipids that provide a readily available source of metabolic energy. MCT oil is predominantly composed of caprylic acid (C8) and capric acid (C10), which are rapidly digested, absorbed through the portal circulation, and transported to the liver for β-oxidation, resulting in acetyl-CoA formation, ATP generation, and ketone-body production. Unlike coconut oil, which contains a mixture of fatty acids with a high proportion of lauric acid (C12), MCT oil provides a concentrated source of rapidly metabolized medium-chain fatty acids. The present study was undertaken to develop and evaluate an MCT-based oral energy shot for rapid energy delivery. MCT oil was prepared through raw-material procurement and authentication, preliminary preparation, extraction using the Pre-activated Vedic Methodology for Extraction, filtration, concentration, and standardization. The extracted oil was evaluated for chemical and physicochemical characteristics, phytochemical profile, chromatographic characteristics where applicable, antioxidant activity, microbial quality, and heavy-metal and contamination status. The standardized MCT oil was formulated into an oral shot and evaluated for formulation characteristics, packaging, storage, and stability. The energy value was calculated based on the MCT content of the formulation. The study further considered the complete metabolic pathway of MCTs, including intestinal digestion, portal absorption, hepatic β-oxidation, acetyl-CoA formation, ATP generation, and ketogenesis. A preclinical safety evaluation using guinea pigs was incorporated to assess the tolerability and safety of the developed formulation under defined experimental conditions. Energy values were calculated theoretically from MCT content and were not experimentally measured. Overall, the study integrated MCT production, characterization, metabolic energy delivery, oral-shot formulation, stability assessment, and preclinical safety evaluation to develop a standardized MCT-based functional energy formulation.
References
2.Watanabe S, Tsujino S. Applications of medium-chain triglycerides in foods. Front Nutr. 2022;9:802805. doi:10.3389/fnut.2022.802805.
3.Lee YY, Tang TK, Phuah ET, et al. Medium chain triglyceride and medium-and long chain triglyceride: metabolism, production, health impacts and its applications—a review. Crit Rev Food Sci Nutr. 2022;62(15):4169-4185. doi:10.1080/10408398.2021.1873729.
4.Wang Y, Zhang T, Liu R, et al. Reviews of medium- and long-chain triglyceride with respect to nutritional benefits and digestion and absorption behavior. Food Res Int. 2022;155:111058. doi:10.1016/j.foodres.2022.111058.
5.Cao Y, Kanta JM, Bishop CA, Kiens B, Fritzen AM, Kleinert M. Dietary medium-chain triacylglycerols in metabolic regulation. Trends Endocrinol Metab. 2026;37(6):511-533. doi:10.1016/j.tem.2025.09.010.
6.Medium-Chain Triglycerides: Scientific and Regulatory Perspectives from Germany and Japan with a US Context—A Concise Review. Nutrients. 2026;18(7):1027. doi:10.3390/nu18071027.
7.Clément J. Digestion and absorption of dietary triglycerides. J Physiol (Paris). 1976;72(2):137-170.
8.St-Onge MP, Jones PJH. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. J Nutr. 2002;132(3):329-332. doi:10.1093/jn/132.3.329.
9.Hill JO, Peters JC, Yang D, et al. Thermogenesis in humans during overfeeding with medium-chain triglycerides. Metabolism. 1989;38(7):641-648. doi:10.1016/0026-0495(89)90101-7.
10.Scalfi L, Coltorti A, Contaldo F. Postprandial thermogenesis in lean and obese subjects after meals supplemented with medium-chain and long-chain triglycerides. Am J Clin Nutr. 1991;53(5):1130-1133. doi:10.1093/ajcn/53.5.1130.
11.St-Onge MP, Bosarge A. Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. Am J Clin Nutr. 2008;87(3):621-626. doi:10.1093/ajcn/87.3.621.
12.Mumme K, Stonehouse W. Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. J Acad Nutr Diet. 2015;115(2):249-263. doi:10.1016/j.jand.2014.10.022.
13.Bueno NB, de Melo IV, Florêncio TT, Sawaya AL. Dietary medium-chain triacylglycerols versus long-chain triacylglycerols for body composition in adults: systematic review and meta-analysis of randomized controlled trials. J Am Coll Nutr. 2015;34(2):175-183. doi:10.1080/07315724.2013.879844.
14.Maher T, Clegg ME. A systematic review and meta-analysis of medium-chain triglycerides effects on acute satiety and food intake. Crit Rev Food Sci Nutr. 2021;61(4):636-648. doi:10.1080/10408398.2020.1742654.
15.St-Onge MP, Mayrsohn B, O'Keeffe M, Kissileff HR, Choudhury AR, Laferrère B. Impact of medium and long chain triglycerides consumption on appetite and food intake in overweight men. Eur J Clin Nutr. 2014. doi:10.1038/ejcn.2014.145.
16.Chapman-Lopez TJ, Koh Y. The effects of medium-chain triglyceride oil supplementation on endurance performance and substrate utilization in healthy populations: a systematic review. J Obes Metab Syndr. 2022;31(3):217-229. doi:10.7570/jomes22028.
17.Jeukendrup AE, Thielen JJHC, Wagenmakers AJM, Brouns F, Saris WHM. Effect of medium-chain triacylglycerol and carbohydrate ingestion during exercise on substrate utilization and subsequent cycling performance. Am J Clin Nutr. 1998;67(3):397-404. doi:10.1093/ajcn/67.3.397.
18.Jeukendrup AE, Saris WHM, Schrauwen P, Brouns F, Wagenmakers AJM. Metabolic availability of medium-chain triglycerides coingested with carbohydrates during prolonged exercise. J Appl Physiol. 1995;79(3):756-762. doi:10.1152/jappl.1995.79.3.756.
19.Jeukendrup AE, Saris WHM, Van Diesen R, Brouns F, Wagenmakers AJM. Effect of endogenous carbohydrate availability on oral medium-chain triglyceride oxidation during prolonged exercise. J Appl Physiol. 1996;80(3):949-954. doi:10.1152/jappl.1996.80.3.949.
20.Vandenberghe C, St-Pierre V, Pierotti T, Fortier M, Castellano CA, Cunnane SC. Tricaprylin alone increases plasma ketone response more than coconut oil or other medium-chain triglycerides: an acute crossover study in healthy adults. Curr Dev Nutr. 2017.
21.Vandenberghe C, Castellano CA, Maltais M, et al. Emulsification increases the acute ketogenic effect and bioavailability of medium-chain triglycerides in humans. Curr Dev Nutr. 2018.
22.Vandenberghe C, et al. Plasma ketone and medium-chain fatty acid response in humans consuming different medium-chain triglycerides during a metabolic study day. Front Nutr. 2019.
23.Ketogenic effects of medium chain triglycerides containing formula and its correlation to breath acetone in healthy volunteers: a randomized, double-blinded, placebo-controlled, single dose-response study. Front Nutr. 2023;10:1224740. doi:10.3389/fnut.2023.1224740.
24.Fortier M, Castellano CA, Croteau E, et al. A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimers Dement. 2019.
25.Fortier M, et al. A ketogenic drink improves cognition in mild cognitive impairment: results of a 6-month randomized controlled trial. Alzheimers Dement. 2021. doi:10.1002/alz.12206.
26.Avgerinos KI, Egan JM, Mattson MP, Kapogiannis D. Medium chain triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease: a systematic review and meta-analysis of human studies. Ageing Res Rev. 2020;58:101001. doi:10.1016/j.arr.2019.101001.
27.Zhou S, Wang Y, Jiang Y, Yu LL. Safety assessment of medium- and long-chain triacylglycerols containing 30% (w/w) medium-chain fatty acids in mice and rats. Regul Toxicol Pharmacol. 2017;86:42-48.
28.Vasconcelos LHC, Silva MCC, et al. Virgin coconut oil supplementation prevents airway hyperreactivity of guinea pigs with chronic allergic lung inflammation by antioxidant mechanism. Oxid Med Cell Longev. 2020;2020:5148503. doi:10.1155/2020/5148503.
29.Neurodegenerative protection with Orgaheal medium-chain triglycerides oil: evidence from cell cultures, enzyme inhibition studies, and measurement of antioxidant and lipid-lowering properties. PubMed PMID: 40643181. This study reported a C8/C10-rich MCT oil containing approximately 56% C8 and 43% C10 and evaluated DPPH and nitric-oxide radical scavenging activity.
30.Inhibition of Candida mycelia growth by medium-chain fatty acids, capric acid in vitro and its therapeutic efficacy in murine oral candidiasis. Med Mycol J. 2012;53:255-261. doi:10.3314/mmj.53.255.

